ONEvite
- Manufacturer
- NEOMED PHARMACEUTICAL
- Effective date
- 2019-06-14
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:49:17
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
STATEMENT OF IDENTITY SECTION
Each Tablet Contains:
Other Ingredients: Di calcium phosphate, microcrystalline cellulose, croscarmellose sodium, stearic acid, silicon dioxide, titanium dioxide, PEG 8000, magnesium stearate, talc, HPMC E15 & HPMC E5/E6
WARNINGS SECTION
INDICATIONS AND USAGE
ONEvite Tablets is an orally administered prescription vitamin supplement specifically formulated for the clinical dietary management of patients with unique nutritional needs requiring, increased folate levels and nutritional supplementation in physiologically stressful conditions. As well as for maintenance of good health and beneficial in maintaining overall skin health, also help maintain healthy blood sugar levels and help promote nerve health and function including normal vision.
CONTRAINDICATIONS
ONEvite Tablets is contraindicated in patients with hypersensitivity to any of its components. Folic Acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.
Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (Vitamin B12).
WARNING/PRECAUTIONS
Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.
Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.
The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.
Avoid Over dosage. Keep out of the reach of children.
Drug Interactions
High doses of folic acid may result in decreased serum levels of anticonvulsant drugs.
Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.
Consult appropriate references for additional specific vitamin-drug interactions.
Information for Patients
Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breastfeeding.
Pediatric Use
Not recommended for pediatric use.
ADVERSE REACTIONS
Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in ONEvite T ablets
DOSAGE AND ADMINISTRATION
ONEvite Tablets is a white film coating with caplet shape.
One tablet daily or as directed by a physician.
HEALTH CLAIM SECTION
HOW SUPPLIED
ONEvite Tablets available 90 tablets per bottle,
70898-198-09
Store at room temperature 15°-30°C (59°-86°F). Avoid excessive heat and moisture.
To report a serious adverse event or obtain product information, call 631-524-5758
Manufactured for:
Neomed Pharmaceutical
Brentwood, NY 11717
MADE IN USA
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.
For further information about unapproved drugs, click here.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cf050ccd-1144-f76a-e00d-e5698d8597d4 | Product name | 6 | 20250625 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| b82b4008-22fd-05f5-6cc6-c0a6e81c65b8 | Product name | 2 | 20240805 |
| 91c62db0-0295-c81c-d10a-0856c259edd6 | Product name | 2 | 20200428 |
| d32bc2b8-0bb7-2216-87aa-24639646e202 | Product name | 3 | 20190619 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| d206bb34-ea65-399d-70d9-834f22dc2c18 | Product name | 3 | 20170724 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70898-198-09 | ONEvite | 1 in 1 PACKAGE | TABLET | 1 | 1 | |
| 70898-198-09 | ONEvite | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70898-198-09 | EA - Each | 70898-198 | cf74a8bf-de37-4eb7-b01d-d55c40854e91 | 1 | 2019-06-19 |
Products#
Every source-derived product name is available through these pages.
- ONEvite
- ASCORBIC ACID
- CHOLECALCIFEROL
- THIAMINE HYDROCHLORIDE
- THIAMINE ION
- RIBOFLAVIN
- NIACINAMIDE
- PYRIDOXINE
- FOLIC ACID
- CYANOCOBALAMIN
- BIOTIN
- CALCIUM PANTOTHENATE
- PANTOTHENIC ACID
- VITAMIN A ACETATE
- VITAMIN A
- VANADYL SULFATE
- VANADIUM
- .ALPHA.-LIPOIC ACID
- LUTEIN
- CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
- MICROCRYSTALLINE CELLULOSE
- CROSCARMELLOSE SODIUM
- STEARIC ACID
- SILICON DIOXIDE
- TITANIUM DIOXIDE
- POLYETHYLENE GLYCOL 8000
- MAGNESIUM STEARATE
- TALC
- HYPROMELLOSES
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70898-198 | 70898-198-09 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic acid | ASCORBIC ACID | Zydus Pharmaceuticals USA Inc. | f0b683f8-189b-4a3f-9ffe-f91df6d798b6 | 2026-09-03 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic acid | ASCORBIC ACID | Zydus Lifesciences Limited | d2d29ffd-5483-45bb-9d1b-da7af23b3720 | 2026-09-03 | ASCORBIC ACID | |
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascor | ASCORBIC ACID | McGuff Pharmaceuticals, Inc. | 388aad52-fc01-4784-9791-1dbc80c69306 | 2026-05-29 | Warnings, Adverse reactions | ASCORBIC ACID |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | ASCORBIC ACID |
| Skin Renewing Serum | ASCORBIC ACID | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c2a8d-ac95-cbef-e063-6294a90aff39 | 2025-08-23 | Warnings | ASCORBIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

